-
2021-05-27Butaprost is a selective prostaglandin E receptor (EP2) agonist. Butaprost can effectively mitigate kidney fibrogenesis in various fibrosis models.
Categories
Diseases
Targets
Archives
- May 2021 (1)
Thanks, your subscription has been confirmed. You will hear from us soon.
Submission failed, please try again later.
Products are chemical reagents for research use only and are not intended for human use. We do not sell to patients.